Filing Details
- Accession Number:
- 0001209191-19-023087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-03 16:16:32
- Reporting Period:
- 2019-04-01
- Accepted Time:
- 2019-04-03 16:16:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1505512 | Regulus Therapeutics Inc. | RGLS | Pharmaceutical Preparations (2834) | 264738379 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1706176 | R. Daniel Chevallard | C/O Regulus Therapeutics Inc. 10628 Science Center Dr., #100 San Diego CA 92121 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-04-01 | 3,253 | $0.98 | 9,372 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale of shares of common stock under an existing 10b5-1 Plan to cover tax withholding obligations incurred in connection with the vesting of the restricted stock unit award received by the Reporting Person on 2/5/2019.
Billionaire Hedge Funds
